Grants and Contributions:
Title:
Glyco-RNA potential in therapeutics
Agreement Number:
967265
Agreement Value:
$25,000.00
Agreement Date:
Aug 5, 2021 - Sep 30, 2022
Description:
RNAs were long believed not to be glycosylated. However, a recent report described the discovery of glycosylated RNA species, including Y5 RNA, in mammalian cells. The functional significance of these newly identified molecules is unknown. We propose to investigate the effect glycosylation has on the response of cells in culture to two different RNAs (Poly I:C and Y5 RNA). This work could have an impact in the field of vaccine adjuvants.
Organization:
National Research Council Canada
Expected Results:
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators.
Location:
Quebec, Quebec, CA G1K 9A9
Reference Number:
172-2021-2022-Q2-967265
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
105810
Recipient Type:
Academia
Recipient's Legal Name:
Institut National de la Recherche Scientifique
Federal Riding Name:
Québec
Federal Riding Number:
24059
Program:
Collaborative Science, Technology and Innovation Program – Ideation Fund
Program Purpose:
The Ideation Fund is intended to encourage, test and validate transformative research ideas generated by teams of NRC scientific personnel and external collaborators with complementary capabilities, acting as a demonstration phase for a continually-evolving suite of research and development (R&D) deliverables at the NRC. The fund supports exploratory research through two mechanisms: the New Beginnings Initiative and the Small Teams Initiative.
NAICS Code:
541710